A Universal Bio-Hybrid Nanoparticle Backpack Platform Endows Stem Cells with Microenvironmental Resilience and Sustained Paracrine Signaling
Open Access
- 20 July 2026
- journal article
- Published by Springer Nature in Nano-Micro Letters
- Vol. 18 (1)
Abstract
The therapeutic potential of mesenchymal stem cells (MSCs) in regenerative medicine is frequently thwarted by hostile post-injury microenvironments characterized by oxidative stress, inflammation, and rapid clearance, which compromise cell survival and paracrine efficacy. Herein, we establish a universal bio-hybrid “stem cell backpack” platform designed to fundamentally overcome these bottlenecks through precise surface interface engineering. By tethering drug-loaded mesoporous silica nanoparticles onto the MSCs membrane via mild, biocompatible click chemistry, we create a programmable nanotherapeutic depot that endows host cells with dual, synergistic capabilities: (1) robust scavenging of reactive oxygen species (ROS) to ensure cellular resilience and (2) sustained, localized release of regenerative factors to amplify paracrine signaling. Using corneal chemical injury as a rigorous proof-of-concept model, this platform demonstrated unprecedented regenerative potency. The engineered cells markedly outperformed conventional therapies by simultaneously suppressing inflammatory cascades, preventing fibrosis and neovascularization, and orchestrating multi-lineage regeneration, including epithelial restoration, nerve reinnervation, and limbal stem cell reactivation. Quantitatively, this approach achieved a 63.6% enhancement in transparency restoration and a 76.9% greater reduction in tissue defects compared to cell monotherapy. Crucially, the modular design of this backpack system allows for the interchangeable loading of diverse therapeutics, extending its applicability beyond ophthalmology to other tissues facing similar microenvironmental challenges. This work presents a transformative paradigm in nanomedicine, shifting the focus from passive cell delivery to active microenvironmental modulation, thereby offering a versatile and scalable strategy for next-generation regenerative therapies across diverse clinical indications.Keywords
This publication has 55 references indexed in Scilit:
- Advanced Nanomedicines for Treating Refractory Inflammation-Related DiseasesNano-Micro Letters, 2025
- Dual‐Responsive Multi‐Functional Silica Nanoparticles With Repaired Mitochondrial Functions for Efficient Alleviation of Spinal Cord InjuryExploration, 2025
- Microgels for Cell Delivery in Tissue Engineering and Regenerative MedicineNano-Micro Letters, 2024
- Mesoporous Silica Materials as an Emerging Tool for Cancer ImmunotherapyAdvanced Science, 2022
- Cell Membrane Coating Technology: A Promising Strategy for Biomedical ApplicationsNano-Micro Letters, 2019
- Mesoporous Silica as a Versatile Platform for Cancer ImmunotherapyAdvanced Materials, 2018
- Mesoporous Silica and Organosilica Nanoparticles: Physical Chemistry, Biosafety, Delivery Strategies, and Biomedical ApplicationsAdvanced Healthcare Materials, 2017
- Therapeutic Effect of Human Adipose Tissue-Derived Mesenchymal Stem Cells in Experimental Corneal Failure Due to Limbal Stem Cell Niche DamageStem Cells, 2017
- E-cadherin plays an essential role in collective directional migration of large epithelial sheetsCellular and Molecular Life Sciences, 2012
- Sensory denervation of the rabbit cornea affects epithelial propertiesExperimental Neurology, 1980